investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Elucidating the functions of Bud31, an essential gene in Myc-driven breast cancer
Tiffany Y Hsu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Tiffany Y Hsu
Baylor College of Medicine
Houston, United States
Related projects
Arunasree Kalle
Study the Methylation and Acetylation Status of Xi and Xa Chromosome in Normal and Cancerous Breast Epithelial Cells
Breast
Fergus J Couch
BRCA1 and BRCA2 Missense Mutations and Breast Cancer Risk
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Stanley Lipkowitz
TRAIL-induced Cell Death in Breast Cancer Cells
Breast
Mien-Chie Hung
Nuclear EGFR in Cancer Cell Signaling and Radioresistance
Breast
Radiation Oncology
Vern L. Schramm
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Breast
Ritu Aneja
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
Breast